Publications for Abozguia, K
|Up a level|
Abozguia, K; Elliott, P; McKenna, W; Phan, T T; Nallur Shivu, G; Ahmed, I; Maher, A R; Kaur, K; Taylor, J; Henning, A; Ashrafian, H; Watkins, H; Frenneaux, M (2010). Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy. Circulation, 122(16):1562-1569.
Shivu, G N; Abozguia, K; Phan, T T; Ahmed, I; Henning, A; Frenneaux, M (2010). 31P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3 T. European Journal of Radiology, 73(2):255-259.
Shivu, G N; Phan, T T; Abozguia, K; Ahmed, I; Wagenmakers, A; Henning, A; Narendran, P; Stevens, M; Frenneaux, M (2010). Relationship between coronary microvascular dysfunction and cardiac energetics impairment in type 1 diabetes mellitus. Circulation, 121(10):1209-1215.
Phan, T T; Abozguia, K; Nallur Shivu, G; Mahadevan, G; Ahmed, I; Williams, L; Dwivedi, G; Patel, K; Steendijk, P; Ashrafian, H; Henning, A; Frenneaux, M (2009). Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. Journal of the American College of Cardiology, 54(5):402-409.